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Transport, Not Capture, for Myo2p
 
Budding yeast uses actin and a myosin, Myo2p, to accom-
plish polarized secretion. The simplest model for this pro-
cess, which Schott et al. confirm on page 791, is based on
transport: the Myo2p head walks along actin to growth
sites, with vesicle cargoes attached to its tail. The alterna-
tive is a capture model. In this scenario, the Myo2p tail tar-
gets the protein to the growth site, where it can organize
and polarize actin.
The transport model was in doubt because the original
 
myo2
 
ts
 
 
 
mutant had severe cytoskeletal disorganization,
suggesting an indirect effect on polarity. In more recent
experiments, a tail region alone localized to polarized
sites, but Schott et al. show that this occurs by transport. It
requires a vesicle targeting factor and normal Myo2p,
which presumably carries the extra tails attached to vesicle
cargoes.
Schott et al. isolate seven new 
 
myo2
 
ts
 
 alleles, all mutant
in the tail region. According to the transport model, these
proteins should be competent for their own localization,
but incapable of moving other proteins. Consistent with
this theory, a shift to high temperatures rapidly delocalizes
a secretory vesicle marker, but mutant Myo2p is still local-
ized as long as actin cables are intact. One tail mutant iso-
lated in another study fails to localize, suggesting that even
after transport there may be a mechanism for tethering
Myo2p to the polarization site.
 
Finding a Receptor in cis
 
On page 707, Zeng et al. report an association between
contactin, a glycosylphosphatidylinositol (GPI)-linked re-
ceptor involved in neurite extension and neuronal differ-
 
entiation, and the extracellular domain of PTP
 
a
 
, a recep-
tor protein tyrosine phosphatase (RPTP). PTP
 
a
 
 may link
contactin to the intracellular kinase fyn.
Contactin and PTP
 
a
 
 associate when expressed in the
same cell, but not when they are expressed in two different
cell lines that are then mixed. This cis mode of association
“shows a whole new way of looking at PTPs as receptors,”
says senior author Catherine Pallen. “Finding the extracel-
lular signals [for PTPs] has really stalled the field. But be-
sides looking for the ligand on other cell surfaces we
should be considering [PTPs] as key components of known
receptor complexes.”
 
A New Golgi to ER Transport Pathway
 
ER proteins are recycled from the Golgi using the KDEL
or KKXX motifs and vesicles formed with the COP1 coat-
protein complex. On page 743, and in the November issue
of 
 
Nature Cell Biology
 
 (Girod, A., B. Storrie, J.C. Simp-
son, L. Johannes, B. Goud, L.M. Roberts, J.M. Lord, T.
Nilsson, and R. Pepperkok. 1999. 
 
Nat
 
.
 
 Cell Biol
 
. 1:423–
430), two groups report that some bacterial toxins and
 
Golgi proteins move from the Golgi to the ER using a
different, COP1-independent, but Rab6-dependent, path-
way.
White et al. visualize the Rab6 GTPase as cells internal-
ize the Shiga toxin B-fragment. The proteins colocalize in
transport structures that move from the Golgi to the cell
periphery, before the toxin fragment disperses into the
ER. This trafficking is unaffected by antibodies to COP1
that inhibit KDEL-mediated transport, but a Rab6 mutant
reduces toxin delivery to the ER and, therefore, toxicity.
Girod et al. report similar trafficking results with both
Shiga-like toxin and a Golgi-resident glycosylation en-
zyme. The Rab6 pathway may use delivery to the ER to
weed out misfolded Golgi proteins or to recycle excess lip-
ids from the trans-Golgi network.
 
Assembling snRNPs in Cajal Bodies
 
The spinal muscular atrophy disease gene product (SMN)
has been implicated in the assembly of spliceosomal small
nuclear ribonucleoproteins (snRNPs). In previous studies,
snRNPs were localized to nuclear structures called coiled,
or Cajal, bodies, and SMN was found in neighboring gems.
How the two ever got together was a mystery.
On page 715, Carvalho et al. report that, in most cell
types, SMN is found predominantly in Cajal bodies, fur-
ther strengthening the idea that Cajal bodies are a site for
assembly or processing of spliceosome components. Gems
appear to be SMN aggregates, present only in a subset of
cells, and their function remains unclear.
Most snRNAs are exported to the cytoplasm after tran-
scription. They then assemble with Sm proteins and re-
enter the nucleus. Carvalho et al. use leptomycin to block
 
snRNA export, which leads to a gradual depletion of
snRNPs from the Cajal bodies. This transient association
with Cajal bodies is consistent with the findings of Slee-
man and Lamond (Sleeman, J.E., and A.I. Lamond. 1999.
 
Curr
 
.
 
 Biol
 
. 9:1065–1074), who see a pulse of labeled Sm
proteins move from the cytoplasm to the Cajal bodies, and
then on to nuclear speckles, which are reservoirs from
which splicing factors are recruited to splicing sites. Thus,
the Cajal body seems to be a transit site where a particular
(and, as yet, unidentified) spliceosome biogenesis step
takes place.
 
The Point of No Return for Apoptosis
 
Some cells, such as neurons, can recover from the mito-
chondrial release of cytochrome 
 
c
 
 that normally initiates
apoptosis. On page 809, Kluck et al. identify a permeabil-
ity enhancing factor (PEF) which may ensure that other
cells fully commit to apoptosis.
Kluck et al. find that mitochondria in frog extract re-
lease cytochrome 
 
c
 
 and two other proteins from the mito-
chondrial intermembrane space, suggesting that any chan-
nel for cytochrome 
 
c
 
 is not specific to that protein. But,
proteins are not released from the matrix compartment,
which shows no signs of swelling or visible damage.
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The apoptosis-initiating proteins, Bid and Bax, produce
similar effects. However, only extract treatment opens up
mitochondria enough so that large amounts of exogenous
cytochrome 
 
c
 
 can re-enter mitochondria and gain access to
oxidizing or reducing complexes. Kluck et al. name this ex-
tract factor PEF. A PEF-treated mitochondrion’s ability to
re-admit cytochrome 
 
c
 
 may be an indicator of a more ex-
tensive and permanent opening of mitochondrial channels.
“PEF might ensure that the mitochondria can’t recover,”
says senior author Donald Newmeyer.
PEF does not consist of, but is, in fact, destroyed by, the
 
cell death proteases or caspases. Thus, therapeutic inhibi-
tion of caspase activity may have the unintended conse-
quence of increasing PEF activity and reinforcing cell
death. Newmeyer is now testing to see if neurons (which
can recover from cytochrome 
 
c
 
 release) lack PEF activity
and if PEF activity is generally higher in cells that are
readily replaceable.
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